甲状腺眼病的医学管理。
Medical management of thyroid eye disease.
作者信息
Yang Dawn D, Gonzalez Mithra O, Durairaj Vikram D
机构信息
University of Colorado Denver School of Medicine, Department of Ophthalmology, Division of Oculofacial Plastic and Reconstructive Surgery, United States.
出版信息
Saudi J Ophthalmol. 2011 Jan;25(1):3-13. doi: 10.1016/j.sjopt.2010.10.001. Epub 2010 Oct 26.
Abstract
Thyroid eye disease (TED) is the most common cause of orbital disease in adults. The immunologic pathogenesis of TED has been an area of active research and considerable progress has resulted in an expansion of therapeutic options. Although surgical intervention may be required, a majority of TED patients can be managed with medical therapies. Of medical therapies, glucocorticoids remain the agent of choice in the control of TED activity. The objective of this review is to discuss the paradigm and options in medical management of TED.
摘要
甲状腺眼病（TED）是成人眼眶疾病最常见的病因。TED的免疫发病机制一直是积极研究的领域，并且取得了相当大的进展，从而扩大了治疗选择。虽然可能需要手术干预，但大多数TED患者可以通过药物治疗来管理。在药物治疗中，糖皮质激素仍然是控制TED活动的首选药物。本综述的目的是讨论TED药物治疗的模式和选择。
相似文献
1
Medical management of thyroid eye disease.甲状腺眼病的医学管理。
Saudi J Ophthalmol. 2011 Jan;25(1):3-13. doi: 10.1016/j.sjopt.2010.10.001. Epub 2010 Oct 26.
2
[Pathogenesis of thyroid eye disease - does autoimmunity against the TSH receptor explain all cases?].[甲状腺眼病的发病机制——针对促甲状腺激素受体的自身免疫能解释所有病例吗？]
Endokrynol Pol. 2011;62 Suppl 1:1-7.
3
Pathogenesis of thyroid eye disease--does autoimmunity against the TSH receptor explain all cases?甲状腺眼病的发病机制——抗 TSH 受体自身免疫能否解释所有病例？
Endokrynol Pol. 2010 Mar-Apr;61(2):222-7.
4
Eyelid Surgery in Thyroid Eye Disease.甲状腺眼病的眼睑手术。
Ophthalmic Plast Reconstr Surg. 2023 Dec 1;39(6S):S92-S104. doi: 10.1097/IOP.0000000000002543. Epub 2023 Dec 4.
5
Advances in the management of thyroid eye diseases: An overview.甲状腺眼病的管理进展：综述
Int Ophthalmol. 2018 Oct;38(5):2247-2255. doi: 10.1007/s10792-017-0694-0. Epub 2017 Aug 18.
6
Corticosteroids in Moderate-To-Severe Graves' Ophthalmopathy: Oral or Intravenous Therapy?中重度格雷夫斯眼病的皮质类固醇治疗：口服还是静脉治疗？
Int J Environ Res Public Health. 2019 Jan 8;16(1):155. doi: 10.3390/ijerph16010155.
7
Prognostic indicators for the development of strabismus among patients with graves' ophthalmopathy.格雷夫斯眼病患者斜视发生的预后指标。
J Clin Transl Endocrinol. 2017 Jul 11;9:38-40. doi: 10.1016/j.jcte.2017.06.005. eCollection 2017 Sep.
8
Knowledge of Thyroid Eye Disease in Graves' Disease Patients With and Without Orbitopathy.甲状腺眼病在 Graves 病伴和不伴眼眶病患者中的认识。
Thyroid. 2019 Apr;29(4):557-562. doi: 10.1089/thy.2018.0665. Epub 2019 Mar 22.
9
Demographic and clinical profile of 1000 patients with thyroid eye disease presenting to a Tertiary Eye Care Institute in India.印度一家三级眼科保健机构收治的 1000 例甲状腺眼病患者的人口统计学和临床特征。
Int Ophthalmol. 2021 Jan;41(1):231-236. doi: 10.1007/s10792-020-01571-6. Epub 2020 Aug 25.
10
Management of Thyroid Eye Disease-Related Strabismus.甲状腺眼病相关斜视的管理
J Curr Ophthalmol. 2020 Mar 23;32(1):1-13. doi: 10.1016/j.joco.2019.10.002. eCollection 2020 Jan-Mar.
引用本文的文献
1
Efficacy and safety of various Intravenous Methylprednisolone regimens in Moderate to Severe Thyroid Eye Disease: A systematic review.不同静脉注射甲泼尼龙方案治疗中重度甲状腺眼病的疗效与安全性：一项系统评价
Indian J Ophthalmol. 2025 Aug 1;73(8):1100-1107. doi: 10.4103/IJO.IJO_1808_24. Epub 2025 Jul 28.
2
[Clinical and immunological predictors of Graves' orbitopathy after radioiodine therapy of Graves' disease].[Graves病放射性碘治疗后Graves眼病的临床及免疫预测因素]
Probl Endokrinol (Mosk). 2023 Nov 10;69(5):16-24. doi: 10.14341/probl13293.
3
Low- vs. high-dose radiotherapy in Graves' ophthalmopathy: a retrospective comparison of long-term results.格雷夫斯眼病低剂量与高剂量放疗的长期疗效比较：一项回顾性研究。
Strahlenther Onkol. 2021 Oct;197(10):885-894. doi: 10.1007/s00066-021-01770-9. Epub 2021 Apr 16.
4
Medical management of thyroid eye disease - A paradigm shift.甲状腺眼病的医学管理——一种范式转变。
Indian J Ophthalmol. 2020 Aug;68(8):1515-1518. doi: 10.4103/ijo.IJO_2386_20.
5
Cervicogenic exophthalmos: Possible etiology and pathogenesis.颈源性眼球突出：可能的病因及发病机制。
World J Clin Cases. 2020 Jan 26;8(2):318-324. doi: 10.12998/wjcc.v8.i2.318.
6
Tocilizumab for thyroid eye disease.托珠单抗用于治疗甲状腺眼病。
Cochrane Database Syst Rev. 2018 Nov 27;11(11):CD012984. doi: 10.1002/14651858.CD012984.pub2.
7
Short and long-term effects of high-dose intravenous methylprednisolone pulse therapy on thyroid-associated ophthalmopathy.大剂量静脉注射甲泼尼龙冲击疗法对甲状腺相关性眼病的短期和长期影响。
Exp Ther Med. 2016 Aug;12(2):901-908. doi: 10.3892/etm.2016.3446. Epub 2016 Jun 9.
8
Update in oculoplastic imaging.眼部整形影像学进展
Saudi J Ophthalmol. 2012 Oct;26(4):347-8. doi: 10.1016/j.sjopt.2012.11.001. Epub 2012 Nov 10.
9
Thyroid associated orbitopathy: Understanding pathophysiology.甲状腺相关性眼病：了解其病理生理学
Saudi J Ophthalmol. 2011 Jan;25(1):1-2. doi: 10.1016/j.sjopt.2010.11.001. Epub 2010 Nov 11.
本文引用的文献
1
Risk factors for development or deterioration of Graves' ophthalmopathy.格雷夫斯眼病发生或恶化的危险因素。
Thyroid. 2010 Jul;20(7):777-83. doi: 10.1089/thy.2010.1634.
2
Pathophysiology of Graves' ophthalmopathy.格雷夫斯眼病的病理生理学
Pediatr Endocrinol Rev. 2010 Mar;7 Suppl 2:178-81.
3
Update on the medical treatment of Graves' ophthalmopathy.格雷夫斯眼病的医学治疗进展。
Int J Gen Med. 2009 Dec 29;2:263-9. doi: 10.2147/ijgm.s6856.
4
5
Thyroidectomy in Graves' disease: subtotal, near total or total?格雷夫斯病的甲状腺切除术：次全切除、近全切除还是全切除？
Orbit. 2009;28(4):241-4. doi: 10.1080/01676830903104595.
6
Rituximab treatment of patients with severe, corticosteroid-resistant thyroid-associated ophthalmopathy.利妥昔单抗治疗严重、皮质类固醇抵抗的甲状腺相关眼病患者。
Ophthalmology. 2010 Jan;117(1):133-139.e2. doi: 10.1016/j.ophtha.2009.05.029. Epub 2009 Oct 8.
7
Thyroid-associated ophthalmopathy after treatment for Graves' hyperthyroidism with antithyroid drugs or iodine-131.使用抗甲状腺药物或碘-131治疗格雷夫斯甲亢后出现的甲状腺相关眼病。
J Clin Endocrinol Metab. 2009 Oct;94(10):3700-7. doi: 10.1210/jc.2009-0747. Epub 2009 Sep 1.
8
Treatment modalities for Graves' ophthalmopathy: systematic review and metaanalysis.格雷夫斯眼病的治疗方式：系统评价与荟萃分析
J Clin Endocrinol Metab. 2009 Aug;94(8):2708-16. doi: 10.1210/jc.2009-0376. Epub 2009 Jun 2.
9
Graves ophthalmopathy: the bony orbit in optic neuropathy, its apical angular capacity, and impact on prediction of risk.格雷夫斯眼病：视神经病变中的眼眶骨骼、其尖部角度容量及其对风险预测的影响。
AJNR Am J Neuroradiol. 2009 Mar;30(3):597-602. doi: 10.3174/ajnr.A1413. Epub 2009 Jan 15.
10
Repeated peribulbar injections of triamcinolone acetonide: a successful and safe treatment for moderate to severe Graves' ophthalmopathy.曲安奈德球周重复注射：一种治疗中重度格雷夫斯眼病的安全有效方法。
Acta Ophthalmol. 2009 Feb;87(1):58-64. doi: 10.1111/j.1755-3768.2008.01171.x. Epub 2008 Oct 7.
Zotero 插件